McKinsey September 24, 2024
The impending AI–driven life science revolution promises transformative effects on human health and well-being. An accelerated drug discovery process, for example, can help cure more diseases more quickly, opening additional resources that could then be applied to currently underserved areas. With rarer forms of disease, including some of the hardest-to-treat cancers, the potential for AI to impact drug discovery and development holds significant promise for saving lives, reducing costs, and catalyzing further research.
Our feature in the Rewriting Cancer digital series explores AI’s potential to accelerate drug discovery and development in cancer care, and what is required to...
Today's Sponsors
Today's Sponsor